Inhaled mannitol shifts exhaled nitric oxide in opposite directions in asthmatics and healthy subjects

被引:18
作者
Högman, M
Lúdvíksdóttir, D
Anderson, SD
George, S
Håkansson, L
Chan, HK
Meriläinen, P
Hedenström, H
机构
[1] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden
[2] Uppsala Univ, Akad Sjukhuset, Dept Resp Med & Allergol, Uppsala, Sweden
[3] Royal Prince Alfred Hosp, Dept Thorac Med, Camperdown, NSW 2050, Australia
[4] Univ Calif Irvine, Dept Chem & Biochem Engn & Mat Sci, Irvine, CA USA
[5] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
[6] Univ Sydney, Dept Pharm, Sydney, NSW 2006, Australia
来源
RESPIRATION PHYSIOLOGY | 2001年 / 124卷 / 02期
关键词
disease; asthma; mammals; humans; mediator; NO; pharmacological agents; mannitol; upper airways; inflammation;
D O I
10.1016/S0034-5687(00)00195-X
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We investigated if healthy subjects could release NO upon hyperosmolar challenge as a defence mechanism, and whether asthmatics with atopy showed an altered response. A plot Of NO output versus ROW rate was used to calculate the alveolar level and the NO-flux from the airways. The asthmatics had a higher NO output and this was: due to an increased NO-flux from the airways, 86 +/- 30 nl min(-1) compared with control 21 +/- nl min(-1) (P < 0.05). The alveolar NO levels showed no difference. In response to a dry powder of mannitol the exhaled NO concentration decreased in asthmatics by 37 +/- 7%, but increased in the control by 9 +/- 4% (P < 0.001). The FEV1.0 decreased 13 +/- 2% and airway conductance 42 +/- 7% in asthmatics and in the controls 2 +/- 1% and 0 +/- 7%, respectively (P < 0.001). We conclude that asthmatics have an altered response to mannitol challenge in regards to exhaled NO. This may result from down regulation of constitutive NO production as a result of high levels of NO flux from the airways. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 31 条
[21]   METHACHOLINE BRONCHIAL CHALLENGE USING A DOSIMETER WITH CONTROLLED TIDAL BREATHING [J].
NIEMINEN, MM ;
LAHDENSUO, A ;
KELLOMAEKI, L ;
KARVONEN, J ;
MUITTARI, A .
THORAX, 1988, 43 (11) :896-900
[22]   NITRIC-OXIDE SYNTHESIS INHIBITORS INDUCE AIRWAY HYPERRESPONSIVENESS IN THE GUINEA-PIG IN-VIVO AND IN-VITRO - ROLE OF THE EPITHELIUM [J].
NIJKAMP, FP ;
VANDERLINDE, HJ ;
FOLKERTS, G .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (03) :727-734
[23]   ALLERGEN-INDUCED AIRWAY-OBSTRUCTION IN GUINEA-PIGS IS ASSOCIATED WITH CHANGES IN NITRIC-OXIDE LEVELS IN EXHALED AIR [J].
PERSSON, MG ;
GUSTAFSSON, LE .
ACTA PHYSIOLOGICA SCANDINAVICA, 1993, 149 (04) :461-466
[24]   SINGLE-BREATH NITRIC-OXIDE MEASUREMENTS IN ASTHMATIC-PATIENTS AND SMOKERS [J].
PERSSON, MG ;
ZETTERSTROM, O ;
AGRENIUS, V ;
IHRE, E ;
GUSTAFSSON, LE .
LANCET, 1994, 343 (8890) :146-147
[25]   Mannitol and cardiac surgery [J].
Poullis, M .
THORACIC AND CARDIOVASCULAR SURGEON, 1999, 47 (01) :58-62
[26]  
RODWELL LT, 1992, EUR RESPIR J, V5, P953
[27]   BRONCHODILATOR EFFECT SF INHALED NITRIC-OXIDE IN HEALTHY-MEN [J].
SANNA, A ;
KURTANSKY, A ;
VERITER, C ;
STANESCU, D .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (06) :1702-1704
[28]   Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: Effect of aminoguanidine [J].
Scott, JA ;
Machoun, M ;
McCormack, DG .
JOURNAL OF APPLIED PHYSIOLOGY, 1996, 80 (01) :271-277
[29]   INVIVO RELEASE OF INFLAMMATORY MEDIATORS BY HYPEROSMOLAR SOLUTIONS [J].
SILBER, G ;
PROUD, D ;
WARNER, J ;
NACLERIO, R ;
KAGEYSOBOTKA, A ;
LICHTENSTEIN, L ;
EGGLESTON, P .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (03) :606-612
[30]   Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide [J].
Silkoff, PE ;
McClean, PA ;
Slutsky, AS ;
Furlott, HG ;
Hoffstein, E ;
Wakita, S ;
Chapman, KR ;
Szalai, JP ;
Zamel, N .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (01) :260-267